UPXI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
UPXI is not a good buy right now for an impatient investor. Price action is still in a clear downtrend with weakening momentum (bearish MAs and expanding negative MACD), and there is no Intellectia buy signal today. While the options market is positioned bullishly (call-skew), the chart setup suggests the stock can keep drifting lower unless it reclaims key resistance near ~$2.03–$2.26.
Trend is bearish: SMA_200 > SMA_20 > SMA_5 confirms a sustained downtrend. Momentum is deteriorating with MACD histogram at -0.0116 (below zero and negatively expanding). RSI_6 at ~29.7 is near oversold, which can produce bounces, but oversold in a downtrend is not a reliable buy trigger by itself. Price (1.78 post-market) is below S1 (1.796) and below the pivot (2.027), implying sellers still control the tape. Key levels: support S2 ~1.653; resistance pivot ~2.027 then R1 ~2.258. A higher-probability buy setup would require reclaiming and holding above ~2.03 (pivot) and ideally pushing toward ~2.26 (R1).
Intellectia Proprietary Trading Signals:
can reset expectations and drive a repricing. Analyst sees risk/reward appeal tied to the company’s SOL treasury, discounted valuation framework, and a new share repurchase authorization (supportive for sentiment if executed). Options market is positioned bullishly (call-heavy), which can amplify upside on positive news.
Event risk: the upcoming earnings call could disappoint and extend the downtrend. Extremely high volatility (HV ~100.5; IV ~126.
implies large swings that can go against immediate entries quickly.
Latest provided quarter is 2026/Q1: Revenue rose to ~$9.24M (+112.09% YoY), showing strong top-line growth. Gross margin increased to ~87.97 (+43.48% YoY), indicating improved profitability at the gross level. However, bottom-line metrics are unstable: Net income is listed at ~$66.75M with a -4206.12% YoY change and EPS at 0.76 with a -102.44% YoY change—these imply large YoY distortions (likely one-time items, base effects, or accounting noise) and make earnings quality/consistency a key question going into the next report (Q2 2026 call on Feb 10).
Recent analyst action: On 2025-11-14, Cantor Fitzgerald reiterated Overweight but cut its price target sharply to $6 from $16, and removed value attributed to treasury operations from its model. Wall Street pro view: upside optionality from the SOL treasury angle, perceived discounted setup, and buyback authorization. Wall Street con view: the big price-target reduction signals reduced confidence in prior valuation assumptions and highlights sensitivity to treasury/crypto-related modeling and earnings uncertainty. Trading trends show hedge funds and insiders are neutral (no notable accumulation), and there is no recent Congress trading data.
